JP2021530562A5 - - Google Patents
Info
- Publication number
- JP2021530562A5 JP2021530562A5 JP2021522113A JP2021522113A JP2021530562A5 JP 2021530562 A5 JP2021530562 A5 JP 2021530562A5 JP 2021522113 A JP2021522113 A JP 2021522113A JP 2021522113 A JP2021522113 A JP 2021522113A JP 2021530562 A5 JP2021530562 A5 JP 2021530562A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- peptide
- ala
- trp
- tyr
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862694162P | 2018-07-05 | 2018-07-05 | |
| US62/694,162 | 2018-07-05 | ||
| US16/502,215 US10905738B2 (en) | 2018-07-05 | 2019-07-03 | Synthetic peptides, prodrugs, pharmaceutical compositions and uses |
| US16/502,215 | 2019-07-03 | ||
| PCT/BR2019/050249 WO2020006617A1 (en) | 2018-07-05 | 2019-07-04 | Synthetic peptides, prodrugs, pharmaceutical compositions and uses |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021530562A JP2021530562A (ja) | 2021-11-11 |
| JP2021530562A5 true JP2021530562A5 (https=) | 2022-06-24 |
| JP7317956B2 JP7317956B2 (ja) | 2023-07-31 |
Family
ID=69059636
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021522113A Active JP7317956B2 (ja) | 2018-07-05 | 2019-07-04 | 合成ペプチド、プロドラッグ、医薬組成物および使用 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US10905738B2 (https=) |
| EP (1) | EP3818070B1 (https=) |
| JP (1) | JP7317956B2 (https=) |
| KR (1) | KR20210029161A (https=) |
| CN (1) | CN112654634B (https=) |
| BR (1) | BR112021000105A2 (https=) |
| CA (1) | CA3104183A1 (https=) |
| WO (1) | WO2020006617A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024168415A1 (en) * | 2023-02-17 | 2024-08-22 | Biozeus Biopharmaceutical S.A. | Topical peptide formulation for the treatment of sexual dysfunction |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4554101A (en) | 1981-01-09 | 1985-11-19 | New York Blood Center, Inc. | Identification and preparation of epitopes on antigens and allergens on the basis of hydrophilicity |
| AT387234B (de) | 1987-03-05 | 1988-12-27 | Vogelbusch Gmbh | Vorrichtung zur zuechtung von dauerformen insbesondere filamentoeser mikroorganismen |
| US5470949A (en) | 1992-12-15 | 1995-11-28 | The Arizona Board Of Regents On Behalf Of The University Of Arizona | Method for making amino acid glycosides and glycopeptides |
| IL128332A0 (en) | 1996-08-30 | 2000-01-31 | Novo Nordisk As | GLP-1 derivatives |
| AT410798B (de) | 2001-01-26 | 2003-07-25 | Cistem Biotechnologies Gmbh | Verfahren zur identifizierung, isolierung und herstellung von antigenen gegen ein spezifisches pathogen |
| US20030082671A1 (en) | 2001-07-24 | 2003-05-01 | Thomas Hoeg-Jensen | Method for making acylated polypeptides |
| US7585523B2 (en) | 2002-08-27 | 2009-09-08 | Targeted Medical Pharma | Composition and method to augment and sustain neurotransmitter production |
| WO2005097158A1 (en) | 2004-03-29 | 2005-10-20 | The Arizona Board Of Regents On Behalf Of The University Of Arizona | Amphipathic glycopeptides |
| JP2010504336A (ja) | 2006-09-22 | 2010-02-12 | オーソロジック コーポレイション | 血管内皮機能不全を治療する方法 |
| CA2989778C (en) | 2007-01-19 | 2020-06-30 | Kai Pharmaceuticals, Inc. | Method of modifying peptide compositions |
| BRPI0800596A2 (pt) | 2008-01-31 | 2009-09-22 | Univ Minas Gerais | método para a potencialização da função erétil através do uso das composições farmacêuticas de toxina tx2-6 da aranha phoneutria nigriventer |
| CN101585872A (zh) | 2008-05-23 | 2009-11-25 | 成都蓉药集团四川长威制药有限公司 | 重组蛛毒蛋白、其制备方法和表达载体以及用于治疗ed的药物 |
| JP2014500867A (ja) | 2010-11-09 | 2014-01-16 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | 皮膚浸透性および細胞侵入性（ｓｐａｃｅ）ペプチドとその使用法 |
| MX362058B (es) * | 2012-08-20 | 2019-01-07 | Univ Federal De Minas Gerais Ufmg | Péptido pntx(19) sintético, composición farmacéutica y uso. |
| UY35144A (es) | 2012-11-20 | 2014-06-30 | Novartis Ag | Miméticos lineales sintéticos de apelina para el tratamiento de insuficiencia cardiaca |
| WO2015162195A1 (en) | 2014-04-23 | 2015-10-29 | Novo Nordisk A/S | Fatty acid acylated amino acids for oral peptide delivery |
| WO2017068388A2 (pt) | 2015-09-18 | 2017-04-27 | Universidade Federal De Minas Gerais - Ufmg | Uso do peptideo sintetico pntx-19 para tratamento de dor |
| KR101613302B1 (ko) | 2015-12-30 | 2016-04-18 | (주)넥스젠바이오텍 | Sv82 폴리펩타이드 및 이를 유효성분으로 함유하는 피부 주름 개선 및 탄력 유지용 화장료 조성물 |
| KR101636851B1 (ko) * | 2016-06-03 | 2016-07-06 | (주)넥스젠바이오텍 | 피부 세포 증식 효과가 증가한 열 안정성 인간 상피세포성장인자-거미독 융합단백질 및 이를 유효성분으로 함유하는 피부 주름 개선 및 탄력 유지용 화장료 조성물 |
-
2019
- 2019-07-03 US US16/502,215 patent/US10905738B2/en active Active
- 2019-07-04 EP EP19830422.2A patent/EP3818070B1/en active Active
- 2019-07-04 JP JP2021522113A patent/JP7317956B2/ja active Active
- 2019-07-04 KR KR1020207037684A patent/KR20210029161A/ko active Pending
- 2019-07-04 WO PCT/BR2019/050249 patent/WO2020006617A1/en not_active Ceased
- 2019-07-04 CA CA3104183A patent/CA3104183A1/en active Pending
- 2019-07-04 BR BR112021000105-0A patent/BR112021000105A2/pt unknown
- 2019-07-04 CN CN201980057994.1A patent/CN112654634B/zh active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0651765B1 (en) | Analogs of pth and pthrp, their synthesis and use for the treatment of osteoporosis | |
| JP4809352B2 (ja) | 線維芽細胞成長因子２１の突然変異タンパク質 | |
| TWI388333B (zh) | 具有改良性質之重組表面張力素 | |
| JP6069441B2 (ja) | 修飾された血管作動性腸管ペプチド | |
| CN100354306C (zh) | Glp－1衍生物及其经粘膜吸收的制剂 | |
| CA2489227A1 (en) | Hla-a24-restricted cancer antigen peptides | |
| CN115768460A (zh) | 长效glp-1/gip双重激动剂 | |
| JPH06228199A (ja) | 血液脳関門通過可能なペプチド結合体 | |
| JP2026041880A (ja) | 細胞透過性ペプチド変異体およびその用途 | |
| CN100582121C (zh) | 胸腺素β4衍生物及其应用 | |
| EP2185588B1 (en) | Synthetic pulmonary surfactant peptides | |
| JP2005053929A (ja) | 肺胞界面活性タンパク質 | |
| JP2021530562A5 (https=) | ||
| JP2021516222A5 (https=) | ||
| CN101433713A (zh) | GnRH-PE突变体融合蛋白及其用途 | |
| JPH09508377A (ja) | ヒルジンを含んでなる医薬組成物 | |
| JPH06220090A (ja) | ポリペプチド | |
| WO1991007982A1 (en) | Treatment of hsv | |
| JP4427270B2 (ja) | 慢性肺疾患治療剤 | |
| WO2021151853A1 (en) | Polypeptides having improved properties | |
| WO2026055636A1 (en) | Peptides and compositions for improving glucose levels | |
| JP2023543801A5 (https=) | ||
| JPH11100399A (ja) | 新規ペプチド誘導体およびそれを有効成分とする薬剤 | |
| HK1144435A (en) | Synthetic pulmonary surfactant peptides | |
| JPH08333276A (ja) | ペプチド及び気管支拡張剤 |